AKT3 and melanoma: Our data, together with that reported by Boyd et al. [23], suggest that during melanoma development TBX3 expression is transcriptionally regulated by the MAPK pathway and that the stability and oncogenic activity of the TBX3 protein is regulated post-transcriptionally through phosphorylation by AKT3.